genome profiling
Recently Published Documents


TOTAL DOCUMENTS

126
(FIVE YEARS 31)

H-INDEX

23
(FIVE YEARS 3)

Life ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 796
Author(s):  
Yumi Yoshii ◽  
Shunsuke Okazaki ◽  
Masayuki Takeda

Next-generation sequencing-based comprehensive genome profiling (CGP) testing, OncoGuide NCC Oncopanel System, and FoundationOne CDx Cancer Genomic Profile have been covered by the Japanese national health insurance system since June 2019. Because CGP was initially developed to enroll patients into an early-phase clinical trial for solid tumors, its approved indications have been limited to patients who have completed the standard chemotherapy treatment. Approximately 14,000 cases have been registered with the Center for Cancer Genomics and Advanced Therapeutics as of March 2021. Measuring the drug access rate is not enough due to patients’ deteriorating condition during CGP analysis and due to the limited number of ongoing clinical trials available, although tumor-agnostic therapies, such as the use of pembrolizumab in high microsatellite-instable solid tumors and in conditions with a high tumor mutational burden (≥10 mut/Mb) as well as the use of entrectinib and larotrectinib in NTRK fusion-positive tumors have been approved in Japan. Moreover, since this analysis is performed using DNA derived from tumor tissue, it is difficult to perform CGP in cases in which an insufficient amount of tissue exists. Thus, noninvasive blood-based assays have been developed, and CGP panels using circulating tumor DNA from blood were approved in March 2021. However, cost, timing, and the number of tests allowed by the health system have not yet been determined. Therefore, in this review, we outline the current status and issues of CGP testing using tumor tissues as well as the expectations and limitations of liquid biopsy for use in Japanese clinical practice.


2021 ◽  
Vol 32 ◽  
pp. S322
Author(s):  
Nobuhiro Shibata ◽  
Shogen Boku ◽  
Yoshimi Shinomiya ◽  
Hironaga Satake

2021 ◽  
Vol 32 ◽  
pp. S326
Author(s):  
Shusei Tominaga ◽  
Kiyotsugu Iede ◽  
Takesi Chihara ◽  
Amane Yamauchi

2021 ◽  
Author(s):  
Kuniko Sunami ◽  
Hideaki Bando ◽  
Yasushi Yatabe ◽  
Yoichi Naito ◽  
Hideaki Takahashi ◽  
...  

Author(s):  
Patrick da Silva ◽  
Bruna C. Lustri ◽  
Ivana Giovannetti Castilho ◽  
Adriano Martison Ferreira ◽  
Rodrigo T. Hernandes ◽  
...  

Cell Cycle ◽  
2021 ◽  
pp. 1-16
Author(s):  
Siqi Wang ◽  
Gefei Guan ◽  
Cunyi Zou ◽  
Qing Guo ◽  
Wen Cheng ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document